Comparative Pharmacology
Head-to-head clinical analysis: DELFLEX LM W DEXTROSE 2 5 IN PLASTIC CONTAINER versus DIANEAL PD 1 W DEXTROSE 4 25 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DELFLEX LM W DEXTROSE 2 5 IN PLASTIC CONTAINER versus DIANEAL PD 1 W DEXTROSE 4 25 IN PLASTIC CONTAINER.
DELFLEX-LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER vs DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Delflex-LM with Dextrose 2.5% is a peritoneal dialysis solution. Dextrose provides osmotic gradient for ultrafiltration; lactate (LM) is a bicarbonate precursor that buffers metabolic acidosis. The solution replaces fluid and electrolytes while removing waste products via diffusion and convection across the peritoneal membrane.
Intraperitoneal administration of Dianeal PD-1 with 4.25% dextrose creates an osmotic gradient across the peritoneal membrane, promoting ultrafiltration of fluid and removal of uremic solutes (e.g., urea, creatinine) through diffusion and convection.
Intraperitoneal administration: 2 liters of 2.5% dextrose solution per exchange, typically 4 exchanges daily (8 liters total). Adjust volume and frequency based on patient's dry weight, residual renal function, and peritoneal membrane transport characteristics.
Intraperitoneal administration; dose individualized based on body size, residual renal function, and dialysis adequacy. Typical regimen: 2-2.5 L instilled into peritoneal cavity for a dwell time of 4-8 hours, 4-5 exchanges per day in continuous ambulatory peritoneal dialysis (CAPD).
None Documented
None Documented
Dextrose: ~1-2 hours for plasma glucose levels; lactate: ~30-60 minutes for conversion to bicarbonate.
Not applicable; dextrose is continuously absorbed and metabolized; elimination half-life depends on glucose utilization rate (2-4 hours in normal state).
Peritoneal dialysis fluid components: dextrose is metabolized to CO2 and water; lactate is converted to bicarbonate in liver; electrolytes are variably reabsorbed. ~70% of administered dextrose is absorbed; elimination primarily via metabolic pathways.
Dextrose is metabolized to CO2 and water; less than 1% excreted unchanged in urine. No biliary/fecal elimination.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution